Contract orientation and kick-off meeting PP: 9/22/2015 to 12/31/2015
Ended Awarded
- Contract number
- HHSN26100001
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,830
Award facts
- Opportunity
-
- N01CN5500347 Solicitation number
- Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Sep 25, 2015
- Preclinical PREVENT Cancer Program for Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Jan 5, 2015
- Contract value 100% obligated
- $3,830.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 8 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Award Fee
- Place of performance
- Menlo Park, CA 94025, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN26100001?
HHSN26100001 was awarded to Sri International by National Cancer Institute (National Institutes of Health) on September 22, 2015.
How much is contract HHSN26100001 worth?
The government has obligated $3,830 on HHSN26100001.
Is contract HHSN26100001 an order under another contract?
Yes. HHSN26100001 is a delivery order under HHSN261201500041I, an indefinite delivery contract, on PREVENT Cancer Program (PREVENT).
Was contract HHSN26100001 competed?
The extent of competition for HHSN26100001 was full and open competition. The government received 8 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award